The anticonvulsant effect of carbonic anhydrase inhibitors in mice--a noradrenergic mechanism of action.
D000086:Acetazolamide / Q000494:pharmacology; D000596:Amino Acids; D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000494:pharmacology*; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004005:Dichlorphenamide / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology; D004221:Disulfiram / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D005260:Female; D006834:Hydrazines / Q000494:pharmacology; D008704:Methazolamide / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010848:Picolinic Acids / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology
D000596:Amino Acids; D000927:Anticonvulsants; D002257:Carbonic Anhydrase Inhibitors; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D010848:Picolinic Acids; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D004299:Dopamine beta-Hydroxylase; D002262:Carboxy-Lyases; D000086:Acetazolamide; D004221:Disulfiram; D004005:Dichlorphenamide; D008704:Methazolamide